Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound?
The race to dominate the obesity medication market has shifted from a sprint for first-mover advantage to a high-stakes arms race in molecular engineering. While Novo … Read more